Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers January 2013

Launches - A recapitulation of maiden launches in the last 30 days, and related matters

We recently heard of those ex-hedge funders (including a couple from Tudor, a couple from Soros, and a few more from SAC) striking out on their own:

  • Ex-FrontPoint manager Tim Flannery, who ran utility and energy fund Copia Capital, which had to be liquidated in December, is apparently planning a comeback in March.
  • Steve Gross, who was previously portfolio manager at Tudor Investments and before that, partner at Penso Capital Markets and fund manager at Millennium, has just launched AlphaParity in New York and its new fund, the All-Weather Strategy (full Opalesque Exclusive article in AMB and in this publication's Profiles section).
  • Andrew McMillan, Another former portfolio manager at Tudor Investment Corp who oversaw energy investing from Singapore is setting up his own business with five former colleagues. Tudor partners may invest with McMillan when he preps his fund.
  • Imran Hussain, former head of emerging market debt and currency portfolios for BlackRock, quit and partnered with former Octagon Asset Management head portfolio manager Mead Welles to launch a new emerging markets fund in New York called Infineon......................

    To view our full article please login

    This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
    New Managers
    New Managers
    New Managers

  • Today's Exclusives Today's Other Voices More Exclusives
    Previous Opalesque Exclusives                                  
    More Other Voices
    Previous Other Voices                                               
    Access Alternative Market Briefing


    • Top Forwarded
    • Top Tracked
    • Top Searched
    1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

      Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

    2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

      Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

    3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

      From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

    4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

      From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

    5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

      Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its